Other anticoagulants may work via: Blocking Inflammation
Time Point Week 26 What Trials Saw Phase III primary endpoint: VAT reduction of 11.7 to 15.2% versus placebo
Potential Side Effects The administration of Semaglutide, like any pharmacological treatment, comes with the possibility of side effects, which can range from mild to severe and vary from patient to patient
Ro prescribes both branded options (when available) and compounded formulations
Tirzepatide: The Hierarchy Weight Loss Efficacy Retatrutide : 22.5% average (triple-agonist) Tirzepatide : 21% average (dual-agonist) Semaglutide : 15-17% average (single-agonist) Metabolic Rate Impact Retatrutide : 5-10% increase (glucagon pathway) Tirzepatide : 1-2% increase (GIP adds minor boost) Semaglutide : Minimal increase (appetite suppression primary) Muscle Preservation Retatrutide : Excellent (glucagon pathway + higher metabolic rate) Tirzepatide : Good (GIP benefits) Semaglutide : Adequate (GLP-1 only, slower recomposition) Best For Retatrutide : Body recomposition, aggressive fat loss, metabolic health Tirzepatide : Sustained weight loss, transitioning from semaglutide Semaglutide : First-time users, mild obesity, cost-conscious FAQ Q: Is retatrutide better for muscle gain than tirzepatide
